Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 785

1.
2.

Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use.

Miller AL, Dib C, Li L, Chen AY, Amsterdam E, Funk M, Saucedo JF, Wang TY.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):662-71. Epub 2012 Sep 4.

3.

The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).

Goodman SG, Steg PG, Eagle KA, Fox KA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP; GRACE Investigators.

Am Heart J. 2006 Mar;151(3):654-60.

PMID:
16504627
4.

Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.

Kini AS, Lee P, Marmur JD, Agarwal A, Duffy ME, Kim MC, Sharma SK.

Am J Cardiol. 2004 Jan 1;93(1):18-23.

PMID:
14697460
5.

Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.

Somma KA, Bhatt DL, Fonarow GC, Cannon CP, Cox M, Laskey W, Peacock WF, Hernandez AF, Peterson ED, Schwamm L, Saxon LA.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):654-61. Epub 2012 Sep 4.

6.

Quartiles of peak troponin are associated with long-term risk of death in type 1 and STEMI, but not in type 2 or NSTEMI patients.

Gonzalez MA, Porterfield CP, Eilen DJ, Marzouq RA, Patel HR, Patel AA, Nasir S, Lim HM, Babb JD, Rose JD, Cascio WE; Multidisciplinary Atherothrombosis Prevention Program (MAPP).

Clin Cardiol. 2009 Oct;32(10):575-83. doi: 10.1002/clc.20662.

8.

Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.

Fuchs S, Gruberg L, Singh S, Stabile E, Duncan C, Wu H, Waksman R, Satler LF, Pichard AD, Kent KM, Kornowski R.

Am J Cardiol. 2001 Jul 15;88(2):129-33.

PMID:
11448408
9.
11.

Impact of the troponin standard on the prevalence of acute myocardial infarction.

Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL.

Am Heart J. 2003 Sep;146(3):446-52.

PMID:
12947361
13.

[Identification and diagnosis of myocardial damage and acute myocardial infarction during cardiopulmonary resuscitation].

Wang JG, Kong DQ, Huang Y, Huang JY, Zhang ZL, Wu WC, Pan XW.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Jun;21(6):333-6. Chinese.

14.

Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.

Di Chiara A, Dall'Armellina E, Badano LP, Meduri S, Pezzutto N, Fioretti PM.

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):587-92. doi: 10.2459/JCM.0b013e3283383153.

PMID:
20588136
15.

Prognostic factors in patients with minor troponin-I elevation but without acute myocardial infarction.

Lee SH, Yoon SB, Jung JH, Choi SH, Lee N, Cho GY, Oh DJ, Rhim CY, Lee KH.

Coron Artery Dis. 2006 May;17(3):249-53.

PMID:
16728875
16.

Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.

Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF.

J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):7-13. doi: 10.2459/JCM.0b013e32832d83b3.

PMID:
19829142
17.

Implication of cardiac marker elevation in patients who resuscitated from out-of-hospital cardiac arrest.

Oh SH, Kim YM, Kim HJ, Youn CS, Choi SP, Wee JH, Kim SH, Jeong WJ, Park KN.

Am J Emerg Med. 2012 Mar;30(3):464-71. doi: 10.1016/j.ajem.2010.12.022. Epub 2011 Feb 5.

PMID:
21296527
18.
19.

Comparison between cardiac troponin I and CK-MB mass in acute coronary syndrome without st elevation.

Santos ES, Baltar VT, Pereira MP, Minuzzo L, Timerman A, Avezum A.

Arq Bras Cardiol. 2011 Mar;96(3):179-87. Epub 2011 Feb 4. English, Portuguese, Spanish.

Supplemental Content

Support Center